RxDoctor Payments Data

Logan Nichols, PA

Physician Assistant · Casa Grande, AZNPI 1871062125

Payments from drug & device makers

$192in general payments, 2019–2025

Across 11 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$47
  • Lilly USA, LLC$36
  • Astellas Pharma US Inc$29
  • Novo Nordisk$24
  • Merck$15
  • Sanofi-aventis U.S. LLC$15
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$192100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$192 in reported general payments places this provider in the 45th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$4,125
Medicare patients
95
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide93$116,859
JardianceEmpagliflozin74$72,147
OzempicSemaglutide57$57,701
EliquisApixaban54$47,400
MounjaroTirzepatide29$30,726
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$23,893
Tresiba Flextouch U-100Insulin Degludec29$18,808
FarxigaDapagliflozin Propanediol15$16,237
Advair HfaFluticasone Propion/Salmeterol31$15,021
Spiriva RespimatTiotropium Bromide23$14,930
EntrestoSacubitril/Valsartan14$14,514
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$13,857
Lantus SolostarInsulin Glargine,hum.Rec.Anlog93$13,142
LinzessLinaclotide15$12,013
Combivent RespimatIpratropium/Albuterol Sulfate13$10,183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$36$147,585122 claims
Novo NordiskOzempic$24$57,70157 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$47$25,40837 claims
Sanofi-aventis U.S. LLCLantus$15$3,06025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Casa Grande

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →